Pulse Biosciences (PLSE) Gross Margin (2021 - 2026)

Pulse Biosciences (PLSE) posted Gross Margin of 37.1% for Q2 2026, up 2348.39% on a QoQ basis from 1.52% in Q4 2025.

Analysis

Pulse Biosciences (PLSE) Gross Margin (2021 - 2026) Analysis & Trends

Pulse Biosciences has reported Gross Margin for 4 years, with the latest figure at 37.1% in Q2 2026.

On a quarterly basis, Gross Margin changed N/A year-over-year to 37.1% in Q2 2026; TTM through Jun 2026 was 3.57%, a N/A change from a year earlier, with the FY2025 full-year figure at 54.0%, changed N/A from the prior year.
Gross Margin was 37.1% for Q2 2026 at Pulse Biosciences, up from 1.52% in the prior quarter.
The five-year high for Gross Margin was 14444.44% in Q4 2022, with the low at 348.0% in Q2 2022.
Average Gross Margin over 3 years is 2300.98%, with a median of 51.61% recorded in 2022.
The largest YoY upside for Gross Margin was 1449148 bps in 2022 against a maximum downside of 1449148 bps in 2022.
Over 3 years, Gross Margin stood at 14444.44% in 2022, then tumbled by 100 bps to 1.52% in 2025, then surged by 2348 bps to 37.1% in 2026.
The last three Gross Margin figures came in at 37.1% (Q2 2026), 1.52% (Q4 2025), and 224.42% (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	57.71%
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	67.78%
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	64.99%
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	68.27%
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	70.71%
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	77.46%
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	60.21%
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	63.44%
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	45.84%
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00	37.10%

Historic Data

Download Data